Cummins Deutsche Bank has buy rating with target at Rs 1000 per share as domestic business is seeing continued market share gains. It says exports business finally seems to be seeing an improved activity.
Nomura maintains reduce call with target of Rs 690 per share as domestic sales growth remains stable and exports faltered on unsustainably high base from the previous year.
Sun Pharma Deutsche Bank reiterates buy rating, with a target price of Rs 900 per share. It says delay in resolving the warning letter at the Halol plant a downside risk.
JPMorgan is overweight on stock with target price of Rs 865 per share. Macquarie has outperform rating with target of Rs 1000 per share. It says the company should sustain a premium valuation .
Arvind CLSA retain buy call but target is cut to Rs 362 from Rs 366 per share. It says volume-led growth in woven and garments led to beat in textiles revenues.
Ashok Leyland Credit Suisse maintains underperform with target of Rs 77 per share. OMCs Nomura has buy rating on stock with target increased to Rs 1635 from Rs 1250 per share. It has buy rating on IOC with target increased to Rs 700 from Rs 540 per share.
Nomura has buy rating on BPCL with target increased to Rs 740 from Rs 640 per share.
Nomura maintains reduce call with target of Rs 690 per share as domestic sales growth remains stable and exports faltered on unsustainably high base from the previous year.
Sun Pharma Deutsche Bank reiterates buy rating, with a target price of Rs 900 per share. It says delay in resolving the warning letter at the Halol plant a downside risk.
JPMorgan is overweight on stock with target price of Rs 865 per share. Macquarie has outperform rating with target of Rs 1000 per share. It says the company should sustain a premium valuation .
Arvind CLSA retain buy call but target is cut to Rs 362 from Rs 366 per share. It says volume-led growth in woven and garments led to beat in textiles revenues.
Ashok Leyland Credit Suisse maintains underperform with target of Rs 77 per share. OMCs Nomura has buy rating on stock with target increased to Rs 1635 from Rs 1250 per share. It has buy rating on IOC with target increased to Rs 700 from Rs 540 per share.
Nomura has buy rating on BPCL with target increased to Rs 740 from Rs 640 per share.
Investment strategy needs market analysis and experience of stock market. Keen study and observation of stock market leads to best investment strategy that will enhance the profit on investment. Epic Research has experts of market that analyze market for the sack of investors.
ReplyDelete